The public issue is entirely an offer-for-sale (OFS) of up to 21.7 million shares by the promoters and other shareholders to the tune of around ₹1,800 crore, said bankers. The company operates under the “Blue Jet” brand offering niche products targeted at innovator pharmaceutical companies and multinational generic pharmaceutical companies.
Manipal Hospitals is said to plan $1 billion IPO in July
Manipal Health Enterprises is likely to launch its IPO as early as next month, targeting a valuation of around $10 billion. Backed by Temasek, the